A Systematic Review and Economic Evaluation of Alendronate, Etidronate, Risedronate, Raloxifene and Teriparatide for the Prevention and Treatment of Postmenopausal Osteoporosis
Health Technology Assessment - United Kingdom
doi 10.3310/hta9220
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2005
Authors
Publisher
National Institute for Health Research